Professor Daniel Altmann: key facts
- Kind of voice
- Academic
- Role
- professor of immunology at Imperial College London
- Quoted on
- Long Covid, Respiratory (asthma/COPD)
- Tracked press citations
- 2
- Most recently quoted
- 30 Sept 2026
- First quoted
- 10 Sept 2026
“As many of the most severe patients are now 5–6 years into this disabling condition, they do need hope from large clinical trials. A number of further ones are in progress or planned.”
What Professor Daniel Altmann has said
“Using the best candidate drugs from earlier in the appraisal of this disease, the study shows rather modest, short-term benefit, simply showing what an exceptionally challenging condition this is.”
professor of immunology at Imperial College London · Respiratory (asthma/COPD) · 10 Sept 2026 · Commonly-used drugs show small benefit for long-Covid fatigue ↗
Where Professor Daniel Altmann has been quoted
- Health news round-up: 'landmark' long COVID trial results and are contraceptives linked to brain tumours?pharmaceutical-journal.com · 30 Sept 2026
- Commonly-used drugs show small benefit for long-Covid fatiguepulsetoday.co.uk · 10 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.